BlackRock Investment Management’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

BlackRock Investment Management’s Portfolio ANTH Stock Details ANTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$100K	Buy	19,164 +121	+0.6%	+$2.09K	﹤0.01%	3271
2016 Q3	$480K	Buy	19,043 +7	+0%	+$177	﹤0.01%	3068
2016 Q2	$471K	Buy	19,036 +1,160	+6%	+$32.8K	﹤0.01%	3095
2016 Q1	$518K	Buy	17,876 +289	+2%	+$7.84K	﹤0.01%	2889
2015 Q4	$653K	Buy	17,587 +203	+1%	+$8.96K	﹤0.01%	2877
2015 Q3	$847K	Buy	17,384 +1,336	+8%	+$93.3K	﹤0.01%	2714
2015 Q2	$1.11M	Buy	16,048 +15,420	+2,455%	+$714K	﹤0.01%	2691
2015 Q1	$22K	Buy	628 +164	+35%	+$4.85K	﹤0.01%	3430
2014 Q4	$6K	Hold	464	–	–	﹤0.01%	3877
2014 Q3	$7K	Buy	464 +41	+10%	+$863	﹤0.01%	3821
2014 Q2	$11K	Buy	+423	New	+$10.4K	﹤0.01%	3613

Other funds holding ANTH

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

BlackRock Investment Management's ANTH Position: Q4 2016 in Review

BlackRock Investment Management increased its Anthera Pharmaceuticals, Inc. (ANTH) stake by 0.64% in Q4 2016, buying an estimated $2.09K and bringing the position to 19,164 shares worth $100K. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

BlackRock Investment Management first reported a position in ANTH in Q2 2014 and has held it in 11 quarters since. The position peaked at $1.11M in Q2 2015. 72 funds tracked by Wall St. Rank hold ANTH as of Q4 2016.

BlackRock Investment Management held 19,164 shares of Anthera Pharmaceuticals, Inc. worth $100K as of Q4 2016.
BlackRock Investment Management bought 121 Anthera Pharmaceuticals, Inc. shares in Q4 2016, an estimated $2.09K.
Anthera Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3271 holding.
BlackRock Investment Management first reported a position in Anthera Pharmaceuticals, Inc. in Q2 2014 and has held it in 11 quarters since.
BlackRock Investment Management's Anthera Pharmaceuticals, Inc. position peaked at $1.11M in Q2 2015.
72 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.